TER Teradyne, Inc. Common Stock
Teradyne, Inc. Common Stock (TER) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on ARCA. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. If this ticker has no settled sample yet, treat the numbers as a geometric read, not a track record. Information only, not financial advice.
Broken down below
Price has closed below the channel. Support has failed — treat the buy target with caution.
Read from the last 2 years of history we hold: rising, drifting more than +100% a year. The nearest ceiling overhead is US$582.76. What would overturn this: a close below US$509.56 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 2 years read from
- US$509.56 – US$582.76 Rising channel, more than +100% a year
- Position in that channel
- -230% below the floor of it — 0% is the floor, 100% the ceiling
What broke this trend
- The fall
- -34% from US$483.7230 June 2026 → 29 July 2026
- Whose problem it was
- This companyno peer group to compare against
- Does it resolve?
- Temporary falls like it have resolved on the record
- Regained so far
- 6%of what it lost
- What the record says
- 83% of 1178 comparable falls came back, typically in 74 days measured across every stock we hold history for, its peer group being too small
The trend broke in June 2026: price fell 34% from 483.71 to 319.53 by July 2026, and has regained 6% of that fall since. Its peers did not fall with it, so this was about the company rather than its sector. The wire that week: “Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550”. Falls like it have resolved: falls of about 34% here have come back to the old high 83% of the time (1178 comparable falls), typically in 74 days. On that record the fall is treated as temporary, and the trend lines are fitted to the regime it created rather than through it. Priced from that: 489.90 within 787 days, reached 83% of the time in 1178 comparable falls — about 0.06% a day held.
Reported at the time: Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550 — 29 June 2026
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (2 years)
- Lower trend line (2 years)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call today because price has broken 35.0% below the channel floor, which is a fall out of the trend rather than a dip within it. No alerts are sent. The buy and target below are still this site's read of the fitted channel.
Buy now
US$341.37
last close · 16 Sept 2026
Channel buy is US$511.47; last close is the better price available now.
Our target
US$716.50
by 16 Dec 2026
Projected move
109.9%
gross, before costs
Last close is our buy — the best price available now.
- Upper line touches
- 3
- Lower line touches
- 4
- Fit confidence
- 48%
- Fitted
- 15 Sept 2026
Company information
Fundamentals are not available for this instrument from the current data provider.
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.